Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial
Product details
- Glutathione Injection 200MG/ML (30ML), Multi-Dose Vial
Company announcement
Optimal Balance Pharmacy is voluntarily recalling one lot of Compounded Glutathione 200 MG/ML 30 ML Multi-Dose Vials.
The recall was initiated because pharmacy testing identified elevated bacterial endotoxin levels.
The product was distributed to consumers in Arizona, Colorado, Florida, Illinois, Louisiana, Michigan, New York, Nevada, Oklahoma, Pennsylvania, Texas, Utah, Vermont, and Washington.
Adverse events reported include fever, chills, severe headache, nausea, vomiting, pain, and symptoms consistent with an allergic reaction. No deaths have been reported.
The recall was announced on August 19, 2026.
Risk:
There is reasonable probability that injectable products with elevated endotoxin levels could cause significant medical events including fevers, hypotension, inflammatory reactions, anaphylactic shock and death.
Impacted states: Nationwide
Products:
- Glutathione Injection 200MG/ML (30ML) Multi-Dose Vial
Contact
For more information, call (218) 919-2964.
Related recalls
- Argatroban Injection 250 mg/2.5 mL (100 mg/mL)
- Brevital Sodium 500 mg/vial for Injection
- Glutathione Injection
- Dexmedetomidine HCl in 0.9% Sodium Chloride Injection 400 mcg/100 mL (4 mcg/mL) for Intravenous Infusion
- 0.9% Sodium Chloride Injection, USP, 100 mL
- Compounded Glutathione 200 mg/mL 30 mL multidose vial; Myer’s Cocktail 30 mL multidose vial; Tri-Immune Boost 30 mL multidose vial